Patents by Inventor Natalja EIKJE

Natalja EIKJE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10925521
    Abstract: Provided is a formula and method for monitoring individual metabolic response that involve calculation of the lag/latency time (LT) for the peak levels of measured a variety of glucose values by HATR-FTIR (horizontally attenuated total reflection Fourier transform infrared) spectroscopy and the LT for the peak level of capillary blood glucose (CBG), with subsequent calculation of the LT changes between them. Obtained meaningful time-dependent and dose-dependent glucose values and their LT changes characterize glycemic variability (GV) in a qualified subject, that can be used to predict the patient's risk of hyperglycemia, to stage Type II diabetes and, in general, to be considered as a new metrics of assessing the quality of metabolic control.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: February 23, 2021
    Inventor: Natalja Eikje
  • Patent number: 10809187
    Abstract: The invention presents methods of using Fourier transform infrared (FTIR) microspectroscopy for common and specific characterization of carcinogenesis in human skin tumors. The invention provides the user with the method to analyse intra- and inter-molecular interactions for nucleic acids and proteins expressed in infrared (IR) spectra of human skin epidermal cancers towards understanding the molecular, cellular and tissue changes that occur during skin carcinogenesis. More particularly, presented analytical method has the advantage to simultaneously observe DNA-RNA, DNA-DNA, DNA-protein and protein-protein interactions by means of their expressed interacting activity levels within one type of tumour and between different types of tumours, both commonly and specifically, with further indication of the grade of activity in benign, premalignant and malignant skin tissue cells.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: October 20, 2020
    Inventor: Natalja Eikje
  • Patent number: 10801952
    Abstract: The present invention relates to a method for detection in IR (infrared) spectra of human epidermal skin tissue the presence of the multiplet around 1055 cm?1, i.e. the ratio of intensity of the nucleic acids bands, DNA and RNA, indicative for prognosis, diagnosis and prediction of epidermal skin cancers and precancers. Detection of the multiplet together with patterned appearance of DNA/RNA triad peaks at about 1071, 1084/1085 and 1095 cm?1 additionally indicates relation to certain types of tumour and malignancy, also indicating progression of malignancy and progression towards malignancy.
    Type: Grant
    Filed: March 23, 2013
    Date of Patent: October 13, 2020
    Inventor: Natalja Eikje
  • Publication number: 20190317015
    Abstract: The invention presents methods of using Fourier transform infrared (FTIR) microspectroscopy for common and specific characterization of carcinogenesis in human skin tumors. The invention provides the user with the method to analyse intra- and inter-molecular interactions for nucleic acids and proteins expressed in infrared (IR) spectra of human skin epidermal cancers towards understanding the molecular, cellular and tissue changes that occur during skin carcinogenesis. More particularly, presented analytical method has the advantage to simultaneously observe DNA-RNA, DNA-DNA, DNA-protein and protein-protein interactions by means of their expressed interacting activity levels within one type of tumour and between different types of tumours, both commonly and specifically, with further indication of the grade of activity in benign, premalignant and malignant skin tissue cells.
    Type: Application
    Filed: February 21, 2013
    Publication date: October 17, 2019
    Applicant: UNITKA LTD.
    Inventor: NATALJA EIKJE
  • Publication number: 20190310187
    Abstract: The present invention relates to a method for detection in IR (infrared) spectra of human epidermal skin tissue the presence of the multiplet around 1055 cm?1, i.e. the ratio of intensity of the nucleic acids bands, DNA and RNA, indicative for prognosis, diagnosis and prediction of epidermal skin cancers and precancers. Detection of the multiplet together with patterned appearance of DNA/RNA triad peaks at about 1071, 1084/1085 and 1095 cm?1 additionally indicates relation to certain types of tumour and malignancy, also indicating progression of malignancy and progression towards malignancy.
    Type: Application
    Filed: March 23, 2013
    Publication date: October 10, 2019
    Inventor: Natalja EIKJE